{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:27:44Z","timestamp":1747160864424,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.fjurol.2024.102705","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:56:28Z","timestamp":1721854588000},"page":"102705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-865X","authenticated-orcid":false,"given":"\u00c7a\u011fatay","family":"\u00d6zsoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u011fit","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayhan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut Taha","family":"\u00d6l\u00e7\u00fcc\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eahin","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutlu","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2021","series-title":"Estimated number of new cases in 2020, worldwide, both sexes, all ages","author":"Cancer Today","key":"10.1016\/j.fjurol.2024.102705_bib0155"},{"year":"2024","series-title":"Presented at the EAU Annual Congress Paris","key":"10.1016\/j.fjurol.2024.102705_bib0160"},{"key":"10.1016\/j.fjurol.2024.102705_bib0165","first-page":"460","article-title":"Transurethral resection for transitional cell carcinoma","volume":"6","author":"Hall","year":"1992","journal-title":"Prob Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102705_bib0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102705_bib0175","first-page":"127","article-title":"Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2)","volume":"104","author":"Wolf","year":"1987","journal-title":"Scand J Urol Nephrol Supplementum"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102705_bib0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.ju.0000070437.14275.e0","article-title":"Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study","volume":"170","author":"Grimm","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2009.08.024","article-title":"An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer","volume":"57","author":"Kulkarni","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102705_bib0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1100\/tsw.2011.29","article-title":"Role of re-resection in non-muscle-invasive bladder cancer","volume":"11","author":"Herr","year":"2011","journal-title":"Sci World J"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102705_bib0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.eururo.2009.07.032","article-title":"T1HG bladder tumours: so many papers, do we need them? Yes, we do!","volume":"56","author":"Serretta","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0205","first-page":"1416","article-title":"Repeated transurethral resection for non-muscle invasive bladder cancer","volume":"8","author":"Cao","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"22","key":"10.1016\/j.fjurol.2024.102705_bib0210","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.7150\/jca.26129","article-title":"Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade\/grade 3 bladder cancer","volume":"9","author":"Ferro","year":"2018","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102705_bib0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.fjurol.2024.102705_bib0220","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11255-015-1048-3","article-title":"Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer","volume":"47","author":"Koie","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102705_bib0225","doi-asserted-by":"crossref","first-page":"788568","DOI":"10.3389\/fonc.2022.788568","article-title":"Risk stratification for the rate and location of residual bladder tumor for the decision of re-transurethral resection of bladder tumor","volume":"12","author":"Fan","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12957-018-1310-0","article-title":"Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer","volume":"16","author":"Zapa\u0142a","year":"2018","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12885-023-10798-2","article-title":"Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102705_bib0240","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102705_bib0245","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","article-title":"Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","volume":"174","author":"Herr","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102705_bib0250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","volume":"70","author":"Naito","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102705_bib0260","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00345-019-02805-8","article-title":"En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study","volume":"38","author":"Hurle","year":"2020","journal-title":"World J Urol"},{"issue":"9 Pt B","key":"10.1016\/j.fjurol.2024.102705_bib0265","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1464-410X.2008.07966.x","article-title":"Quality control in transurethral resection of bladder tumours","volume":"102","author":"Herr","year":"2008","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102705_bib0270","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1464-410X.1991.tb15100.x","article-title":"Histopathological \u201cself control\u201d in transurethral resection of bladder tumours","volume":"67","author":"Kolozsy","year":"1991","journal-title":"Br J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102705_bib0275","first-page":"121","article-title":"Urothelial dysplasia of the bladder: diagnostic features and clinical significance. Analytical and quantitative cytopathology and histopathology","volume":"35","author":"Lopez-Beltran","year":"2013","journal-title":"Anal Quant Cytopathol Histpathol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102705_bib0280","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0022-5347(06)00267-9","article-title":"Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts","volume":"175","author":"Jones","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102705_bib0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-015-0183-0","article-title":"Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways","volume":"34","author":"Pan","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"issue":"35","key":"10.1016\/j.fjurol.2024.102705_bib0290","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1200\/JCO.2006.08.2073","article-title":"Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification","volume":"24","author":"Mitra","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102705_bib0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/mp.50.6.289","article-title":"Cadherin and catenin biology represent a global mechanism for epithelial cancer progression","volume":"6","author":"Jankowski","year":"1997","journal-title":"Mol Pathol"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102705_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.01.006","article-title":"A preoperative marker panel for the prediction of residual tumor and the decision making for repeat transurethral resection","volume":"33","author":"Liu","year":"2015","journal-title":"Urol Oncol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T02:21:08Z","timestamp":1726453268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024001621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2950393024001621"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102705","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102705"}}